Travere Therapeutics, Inc. (TVTX)

28.51 -1.02 (-3.45%) USD  |  NASDAQ  |  Mar 03, 10:54
More

Travere Therapeutics Stock Based Compensation (5 Year Growth)

Stock Based Compensation (5 Year Growth) Chart

View Stock Based Compensation (5 Year Growth) for TVTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (5 Year Growth) Range, Past 5 Years

View Stock Based Compensation (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (5 Year Growth) Benchmarks

View Stock Based Compensation (5 Year Growth) Benchmarks
Start Trial
Revolution Medicines, Inc. Upgrade
ICU Medical, Inc. Upgrade
Intuitive Surgical, Inc. Upgrade
Tandem Diabetes Care, Inc. Upgrade
iRhythm Holdings, Inc. Upgrade